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A crucial system severely affected in several neuromuscular diseases is the loss
of effective connection between muscle and nerve, leading to a pathological
non-communication between the two tissues. One of the best examples of
impaired interplay between muscle and nerve is Amyotrophic Lateral Sclerosis, a
neurodegenerative disease characterized by degeneration of motor neurons and muscle
atrophy. Increasing evidences suggest that damage to motor neurons is enhanced by
alterations in the neighboring non-neuronal cells and indicate that altered skeletal muscle
might be the source of signals that impinge motor neuron activity and survival. Here we
investigated whether muscle selective expression of SOD1G93A mutant gene modulates
mRNAs and miRNAs expression at the level of spinal cord of MLC/SOD1G93A mice.
Using a Taqman array, the Affymetrix Mouse Gene 2.0 ST approach and the MiRwalk
2.0 database, which provides information on miRNA and their predicted target genes,
we revealed that muscle specific expression of SOD1G93A modulates relevant molecules
of the genetic and epigenetic circuitry of myelin homeostasis in spinal cord of transgenic
mice. Our study provides insights into the pathophysiological interplay between muscle
and nerve and supports the hypothesis that muscle is a source of signals that can either
positively or negatively affect the nervous system.
Keywords: muscle-nerve interplay, miRNA and mRNA signature, ALS, myelination process, SOD1G93A
Abbreviations: ALS, Amyotrophic Lateral Sclerosis; ANOVA, ANalysis Of VAriance; Cldn19, Claudin 19; DAVID, Database
for Annotation Visualization Integrated Discovery; Dhh, Desert hedgehog; DIANA, Dna Intelligence ANAlysis; dmax,
maximum axonal diameter; Dmax, maximum fiber diameter; Dmin, minimum fiber diameter; dmin, minimum axonal
diameter; Drp2, Dystrophin related protein 2; Egr2, Early growth response 2; FC, Fold Change; FVB, Friend leukemia
virus B strain; GEO database, Gene Expression Omnibus database; Gldn, Gliomedin; GO, Gene Ontology; KEGG, Kyoto
Encyclopedia of Genes and Genomes; Mag, Myelin-associated glycoprotein; Matn2, Matrilin 2; mIGF-1, muscle specific
isoform of the Insulin Growth Factor-1; miRNA, miR, microRNA; miRPath, miRNA pathway; MLC, Myosin Light Chain;
Mpz, Myelin protein zero; Nkx2-2, NK2 homeobox 2; Ogn, Osteoglycin; OMIM, Online Mendelian Inheritance in Man;
Pmp22, Peripheral myelin protein 22; Prx, Periaxin; SDS, Sodium Dodecyl Sulfate; Smtn, Smoothelin; SOD1, Superoxide
dismutase 1; STRING, Search Tool for the Retrieval of Interacting Genes/Proteins; TAC, Transcriptome Analysis Console;
UTR, Untranslated region.
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INTRODUCTION
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative
disorder in which the functional connection between nerve
and muscle is severely compromised (Musarò, 2013). ALS
affects pyramidal neurons in the motor cortex and lower motor
neurons originating in the brainstem and in the spinal cord.
The most typical feature of this progressive lethal disease is the
degeneration of motor neurons, muscle weakness and atrophy,
that leads to progressive paralysis and death by respiratory failure
in few years (Musarò, 2010, 2013). ALS is epidemiologically
classified into two major forms: sporadic (90–95%) and familial
(5–10%) form. Among the familial cases, ∼20% are caused
by dominantly inherited mutations in the Cu/Zn superoxide
dismutase (SOD1) protein (Rosen, 1993) a cell scavenger of
superoxide.
One of the critical issue that remains to be addressed in
ALS is whether motor neurons are the first and sole direct
targets of ALS or if the toxic activity of mutant SOD1 is cell
autonomous. Recent experimental evidence revealed that ALS is
a multi-factorial and multi-systemic disease in which alterations
in structural, physiological, andmetabolic parameters in different
cell types, such as motor neurons, glia, and muscle cells, may
act synergistically to exacerbate the disease (Boillée et al., 2006;
Julien, 2007; Musarò, 2013). Skeletal muscle is a source of signals
that influence neuron survival, axonal growth and maintenance
of synaptic connections. Notably, development in the absence
of skeletal muscle results in the sequential ablation of motor
neurons from the spinal cord to the brain (Kablar and Rudnicki,
1999); thus, effective connection between muscle and nerve is
crucial for the survival and function of both tissues throughout
life. We have previously demonstrated that muscle-specific
expression of SOD1 mutation in the MLC/SOD1G93A transgenic
mouse model, which selectively expresses the mutant SOD1G93A
gene in the skeletal muscle under the transcriptional control
of a muscle-specific promoter (MLC), induces accumulation
of Reactive Oxygen Species, causes muscle atrophy with a
concomitant alteration in the ultrastructure and in the functional
performance of skeletal muscles, and promotes microglia
activation in the spinal cord, that is a presymptomatic sign
of ALS disease (Dobrowolny et al., 2008b). Moreover, it
has been reported that skeletal muscle-restricted expression
of the human mutant SOD1 gene causes motor neuron
degeneration in old transgenic mice (Wong and Martin, 2010)
and that muscle-selective alterations in mitochondrial function
initiate neuromuscular junction alteration, distal axonopathy,
astrocytosis, and mild motor neuron loss (Dupuis et al., 2009).
We also demonstrated that forced expression of muscle specific
isoform of the Insulin Growth Factor-1 (mIGF-1) exclusively in
the skeletal muscle of the global SOD1G93A mice counteracted
the symptoms of ALS, induced satellite cell activation, stabilized
neuromuscular junctions, preserved motor peripheral nerve,
and led to a reduction in astrocytosis in the SOD1G93A spinal
cord (Dobrowolny et al., 2005, 2008a). All together these
data indicate that nervous development and homeostasis are
intimately coupled to skeletal myogenesis and muscle function.
Moreover, these findings support the hypothesis that skeletal
muscle is a primary target of mutant SOD1 toxicity in mice
and indicate that altered skeletal muscle impairs motor neuron
activity, suggesting a sequential pattern of degeneration in which
muscle abnormalities precede motor neuron death. In order
to add new insights into the pathogenesis of ALS and define
whether skeletal muscle alteration potentially affect the nervous
system we analyzed the mRNA and miRNA expression in the
lumbar ventral spinal cord of MLC/SOD1G93A transgenic mouse
model (Dobrowolny et al., 2008b). Interestingly, we found that
muscle specific expression of SOD1G93A gene affects spinal cord
miRNome and transcriptome; in particular we observed the
activation of genes involved in the myelination process and a
decrease in the axon diameter to total fiber diameter in the sciatic
nerve, suggesting a myelinopathy in the transgenic mouse model.
MATERIALS AND METHODS
Mice
Animal model used: 4 month old MLC/SOD1G93A mice
overexpressing the mutant SOD1 gene (SOD1G93A) under the
control of the Myosin Light Chain (MLC) muscle specific
promoter (Dobrowolny et al., 2008b) and 4 month old FVB
(Friend leukemia virus B) (control strain). The animals were
housed in a temperature-controlled (22◦C) room with a 12:12 h
light-dark cycle. All animal experiments were approved by
the ethics committee of the Unit of Histology and Medical
Embryology-Sapienza University of Rome- and were performed
in accordance with the current version of the Italian Law on the
Protection of Animals.
RNA Isolation
Total RNA was isolated from frozen lumbar spinal ventral
tissue specimens using pestel homogenization, TRIzol reaction
(Invitrogen, Carlsbad, CA, USA), and further on-column
purification as previously described. The yield, quality and
integrity of RNA were determined using the Agilent 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA) as
previously described (Bernardini et al., 2012).
miRNA Analysis
From each sample (n = 4 per experimental group), 600 ng
of total RNA was reverse transcribed using Taqman MicroRNA
Reverse Transcription Kit with Megaplex Primer Pools A & B
(Applied Biosystems, Foster City, CA, USA). The cDNA was
analyzed with Taqman Array Mouse MicroRNA A and B Cards
Set version 3 (Applied Biosystems, Foster City, CA, USA) on the
Applied Biosystems 7900HT qPCR system (Applied Biosystems,
Foster City, CA, USA). Most of the MicroRNAs in the B Card
were undetermined, therefore their analysis was omitted. The
data was normalized by global mean normalization. SDS RQ
Manager version 2.4 (Applied Biosystems, Foster City, CA, USA)
was used to calculate Ct values (number of cycles required for
the fluorescent signal to cross the set threshold), Ct values greater
than 35 were considered as non-specific or undetected, and were
filtered. MicroRNAs withmissing values in at least 2 of 4 replicate
samples per treatment group were removed from the dataset.
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 December 2015 | Volume 9 | Article 463
Dobrowolny et al. Molecular Signature in MLC/SOD1G93A Spinal Cord
The remaining Ct values were normalized using the U6 reference
miRNA as suggested by manufacturer’s protocol. The fold change
between sample groups was calculated by subtracting the relative
expression of the samples and then transforming the result to
anti-log2 (i.e., 2difference).
Relevant information about the experiment, is available at
http://www.ncbi.nlm.nih.gov/geo/ under accession GSE71193.
miRNA Pathway Analysis
The putative correlation between mRNAs and miRNAs was
investigated through the MiRwalk 2.0, a comprehensive database
that provides information on miRNA from Human, Mouse and
Rat on their predicted as well as validated binding sites on
their target genes. In particular we get information on miRNA
produced by 8 established miRNA prediction programs on
3′ UTRs of all known genes of Mouse (Dweep et al., 2011;
Bernardini et al., 2012).
miRNA predicted pathways were identified using DIANA
(DNA Intelligence Analysis) tools (Vlachos et al., 2012).
DIANA-miRPath is a miRNA pathway analysis web-server
that utilizes predicted miRNA targets (in CDS or 3′-UTR
regions) provided by the DIANA-microT-CDS algorithm or
even experimentally validated miRNA interactions derived from
DIANA-TarBase v6.0. These interactions (predicted and/or
validated) can be subsequently combined with sophisticated
merging and meta-analysis algorithms. Essentially, this tool
allows identifying all the predicted or experimentally validated
miRNAs significantly targeting a selected pathway.
Single qPCR Validation
Single qPCR of miRNA 133a, 133b, 9, 29, 330, and 1 was
performed to validate the performance of the Taqman arrays
using Taqman probes from single tube TaqmanmicroRNA assays
with the diluted cDNA in a 10µl reaction volume, in triplicate for
each assay, on the Applied Biosystems 7500HT system (Applied
Biosystems, Foster City, CA, USA; n = 10 per experimental
group).
Western Blot Analysis
Protein extraction from both wild type and MLC/SOD1G93A
transgenic spinal cord (n = 5 for each genotype) was
performed in 10mM Tris, 150mM Sodium Chloride, 1%
NP40, 0.1% SDS, 10% Glycerol, 1% Deoxycholate, 1mM
Phenylmethylsulfonyl Fluoride, 1µg/ml Aprotinin, 1µg/ml
Leupeptin, 1µg/ml Pepstatin, 1mM Sodium Orthovanadate,
and 1mM Sodium Fluoride. Equal amounts of protein from
each lysate were separated in SDS polyacrilamide gel and
transferred onto a nitrocellulose membrane. Filters were blotted
with antibodies against Pmp22 (Novus Biological Littleton, CO,
USA. Cat. NBP1-67670), Mpz (Abcam, Cambridge, UK. Cat.
Ab64685), and a-tubulin (Sigma, Saint Louis, MO, USA. Cat.
T5168).
Pmp22 primary antibody was diluted 1:200 in TBST and used
for blotting over night (o.n.) after 5%milk saturation. Then, filter
was incubated with secondary antibody (Goat anti-Rabbit IgG
HRP-conjugated) (Bethyl, Montgomery, TX, USA. Cat. A120-
201P) in 1% milk for 1 h.
Mpz primary antibody was diluted 1:500 in TBST and used
for blotting o.n. after 10% milk saturation. Then, filter was
incubated with secondary antibody (Goat anti-Mouse IgG HRP-
conjugated) (Bethyl, Montgomery, TX, USA. Cat. A90-516P) in
1% milk for 1 h.
Tubulin was diluted 1:5000 in TBST and used for blotting
o.n. after 5% milk saturation. Then, filter was incubated with
secondary antibody (Goat anti-Mouse IgG HRP-conjugated)
(Bethyl Montgomery, TX, USA. Cat. A90-516P) in 1% milk
for 1 h. Signals were acquired by ChemiDoc MP instrument
(Bio-Rad, Hercules, CA, USA) and processed with Image Lab
acquisition analysis software (Bio-Rad, Hercules, CA, USA).
Five independent samples for each group of animals have been
used for densitometric analysis and protein level of α-tubulin was
used as control for equal protein loading.
Microarray Analysis
Total RNA was used to create the biotin-labeled library to
be hybridized on GeneChip R© Mouse Gene 2.0 ST Array
(Affymetrix, Santa Clara, CA, USA) covering more than 26500
RefSeq coding transcripts and more than 3500 RefSeq non-
coding transcripts, following the manufacturer protocol.
Briefly, double-stranded cDNA was synthesized routinely
from less than 1 microgram of total RNA primed with a poly-
(dT)—T7 oligonucleotide. The cDNA was used in an in vitro
transcription reaction in the presence of T7 RNA polymerase
and biotin-labeled modified nucleotides during 16 h at 37◦C.
Biotinylated cRNA was purified and then fragmented (35–200
nucleotides), together with hybridization controls and hybridized
to the microarrays for 16 h at 45◦C. Using the GeneChip
Fluidics Station 450 (Affymetrix, Santa Clara, CA, USA), the
biotin-labeled cRNA was revealed by successive reactions
with streptavidin R-phycoerythrin conjugate, biotinylated
anti-streptavidin antibody and streptavidin R-phycoerythrin
conjugate. The arrays were finally scanned in an Affymetrix
GeneChip Scanner 7G Plus (Affymetrix, Santa Clara, CA, USA).
Gene Expression Data
Analysis—Differentially Expressed Gene
List
The CEL files that store the results of the intensity calculations on
the pixel values collected from an Affymetrix scanner and result
from the hybridization, were analyzed using Transcriptome
Analysis Console (TAC) from Affymetrix (Affymetrix, Santa
Clara, CA, USA). Gene-level calculation was performed by
Robust Multichip Average to summarize probeset signal (Irizarry
et al., 2003) and normalization by quantile sketch (Bolstad et al.,
2003). A data table (rma), together with the relative CEL and
relevant information about the experiment, is available at http://
www.ncbi.nlm.nih.gov/geo/ under accession GSE69582.
An unpaired One-way ANOVA was then used to identify
differentially expressed genes, only the genes which met our
criterion (p < 0.05, fold change > 1.5) were selected in this
study. The resulting gene list was then annotated according to
the Gene Ontology (GO) database (www.geneontology.org). This
allowed assigning a category to each gene in the list, according to
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three defined “ontologies” (i.e., terms representing gene product
properties): cellular component, biological process andmolecular
function.
The expression of selected genes was quantified in real time
PCR to obtain an independent validation of microarray data.
Real time PCR was carried out as previously described elsewhere
(Bernardini et al., 2012).
Functional Categorization
The gene expression list has been functionally categorized using
the Database for Annotation, Visualization, and Integrated
Discovery (DAVID; http://david.abcc.ncifcrf.gov/) (Sherman
et al., 2007). The algorithms implemented in this software allow
identifying over-represented gene ontology (GO) terms with
respect to the total number of genes assayed and annotated. To
this aim, DAVID applies a modified Fisher exact test, to establish
if the proportion of genes falling into an annotation category
significantly differs from the background group of genes. In
addition, this tool enables the fine mapping of genes within well-
defined signaling and/or metabolic pathways, classified in the
Kyoto Encyclopedia of Genes and Genomes (KEGG) database
(www.genome.jp/kegg/). The KEGGmapping tool was employed
for the functional categorization of the gene regulatory networks.
For this purpose, AffyGene IDs, corresponding to the genes in
the selected list, were used as queries and the whole set of genes
represented on the array was used as the background group. A
p < 0.05 was set.
The STRING (Search Tool for the Retrieval of Interacting
Genes/Proteins) online software (Franceschini et al., 2013) was
used to search interaction relationships of the proteins encoded
by differential expressed genes.
Histological Analysis
Sciatic nerves were dissected and quickly fixed in 2.5%
glutaraldehyde in 0.1M sodium cacodylate for 2 h, washed in
0.1M sodium cacodylate. Nerves were then post-fixed in 1%
osmium in 0.1M sodium cacodylate for 1 h, dehydrated in
ethanol and embedded in epoxy resin. Samples were infiltrated
with toluene and cut with a Leica ultracut R ultramicrotome
(Leica Microsystems Inc. Buffalo Grove, IL) to obtain 2 um
suitable for toluidine blue staining. Microscope using 40× lenses
was employed, and images were processed using Axiovision Rel
4.8 (Zeiss, Oberkochen, D) representative images of sciatic nerve
thin sections are shown cropped in Figure 5.
The g-ratio was calculated as (dmax + dmin)/2/(Dmax +
Dmin)/2 and the analysis was performed for 200 fibers.
Each diameter was calculated from the average of the major
axis (Dmax: maximum fiber diameter; dmax:maximum axonal
diameter) and the minor axis (Dmin: minimum fiber diameter;
dmin: minimum axonal diameter), (Tsutsumi et al., 2014) and
was measured using Image J software (Image J 1.36, National
Institutes of Health, MD, USA).
Statistical Analysis
Statistical analysis, if not differently specified was performed
using theMannWhitney nonparametric test and significance was
established for p < 0.05.
RESULTS
miRNA and mRNA Expression Profile of
the Spinal Cord of the MLC/SOD1G93A Mice
First, to identify deregulated miRNAs and transcripts in the
spinal cord of MLC/SOD1G93A transgenic mice we performed
miRNA expression profiling and DNA microarray, using the
Taqman array card and Affymetrix Mouse Gene 2.0 ST
respectively (GSE71194). Among the analyzed miRNAs, 54 were
significantly down-regulated (p < 0.05) in the spinal cord
of MLC/SOD1G93A transgenic mice compared to wild type
littermates (Table 1). Of note, the miRnome profiling revealed
the down regulation of mir-330, mir-133, and mir-1, which
are involved in denervation and reinnervation processes (Jeng
et al., 2009; Tsutsumi et al., 2014). In addition mir-29 and mir-9
family member were downregulated and their deregulation was
associated with different neurodegenerative diseases, including
Huntington, Alzheimer, and Parkinson diseases (Saito and Saito,
2012; Tsutsumi et al., 2014) and demyelination-related diseases
(Li and Yao, 2012; Tsutsumi et al., 2014). Real time PCR analysis
was performed to validate the expression of these relevant
miRNAs in the spinal cord of both wild type andMLC/SOD1G93A
transgenic mice (Figure 1).
The microarray data, related to the expression of mRNA in
the spinal cord of both wild type and MLC/SOD1G93A transgenic
mice, were deposited in the GEO database (GSE69582) and
the list of the selected significantly up-regulated and down-
regulated genes (p < 0.05; FC > 1.5) is shown in Tables 2, 3
respectively. Among these genes, nine up-regulated transcripts
are involved in the myelination process such as Peripheral myelin
protein 22 (Pmp22), Myelin protein zero (Mpz), Periaxin (Prx),
the Early growth response 2 (Egr2) genes, Desert hedgehog
(Dhh), or encode for extracellular matrix molecules such as
Matrilin 2 (Matn2), Gliomedin (Gldn), Claudin 19 (Cldn19),
and Smoothelin (Smtn). Other relevant modulated genes include
glycoproteins, such as Osteoglycin (Ogn) and dystroglicans, such
as Dystrophin related protein 2 (Drp2), associated with the
myelination process. The Mpz, Pmp22, Egr2, Prx mRNAs were
selected for validation by qRT-PCR analysis and results are shown
in Figure 2. Opalin, another gene associated to myelin structures,
was down-regulated in the spinal cord of MLC/SOD1G93A
transgenic mice, compared to wild type littermates (Table 3).
Opalin is expressed specifically in late stage of oligodendrocyte
differentiation and has been shown to be dramatically reduced
in a hypomyelination mouse model (Jiang et al., 2013; Tsutsumi
et al., 2014).
In order to show changes in protein expression, as a result
of altered microRNA/mRNA expression, we performed western
blot analysis for Pmp22 and Mpz expression. We revealed a
significant up-regulation of Pmp22 and Mpz proteins in the
spinal cord of MLC/SOD1G93A compared to wild type littermates
(Figure 3), further supporting the evidence that these factors are
targets of specific microRNAs that control the denervation and
reinnervation processes.
Taken together these results suggest that the muscle specific
expression of the mutated isoform of the human SOD1 gene
alters the expression of relevant markers of myelination in
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TABLE 1 | List of significantly down-regulated miRNAs in MLC/SOD1G93A
spinal cord.
miRNA Fold change P-value
mmu-let-7b −4.97 0.04170
mmu-let-7c −4.80 0.01392
mmu-let-7d −3.85 0.02516
mmu-let-7i −3.92 0.04791
mmu-miR-100 −4.31 0.02747
mmu-miR-1 −3.69 0.01614
mmu-miR-106a −5.23 0.02034
mmu-miR-106b −4.57 0.03639
mmu-miR-10a −4.07 0.01796
mmu-miR-10b −3.75 0.03798
mmu-miR-128a −4.69 0.02756
mmu-miR-129-3p −3.55 0.03832
mmu-miR-129-5p −7.58 0.00264
mmu-miR-133a −2.75 0.03894
mmu-miR-133b −3.94 0.00340
mmu-miR-15a −8.16 0.00251
mmu-miR-15b −3.84 0.02226
mmu-miR-17 −4.43 0.04014
mmu-miR-181a −4.35 0.02206
mmu-miR-181c −7.37 0.01568
mmu-miR-188-5p −4.20 0.03755
mmu-miR-192 −3.38 0.04185
mmu-miR-194 −3.60 0.01944
mmu-miR-196b −3.24 0.04461
mmu-miR-199a-3p −4.67 0.01722
mmu-miR-19b −5.56 0.03463
mmu-miR-20b −6.42 0.02596
mmu-miR-23b −4.66 0.04223
mmu-miR-26b −5.25 0.01406
mmu-miR-29a −4.21 0.01571
mmu-miR-29b −6.33 0.01723
mmu-miR-29c −4.38 0.01636
mmu-miR-301a −4.21 0.04486
mmu-miR-30a −3.89 0.03876
mmu-miR-30e −3.37 0.03622
mmu-miR-324-5p −4.63 0.04475
mmu-miR-328 −3.75 0.04278
mmu-miR-329 −4.79 0.01774
mmu-miR-330 −8.50 0.00381
mmu-miR-340-3p −4.96 0.02453
mmu-miR-340-5p −3.83 0.03845
mmu-miR-369-3p −17.18 0.04086
mmu-miR-369-5p −3.64 0.02940
mmu-miR-491 −4.04 0.02354
mmu-miR-497 −6.93 0.00462
mmu-miR-501-3p −3.23 0.00474
mmu-miR-532-5p −4.21 0.04129
mmu-miR-544 −3.89 0.01407
mmu-miR-652 −5.73 0.02815
(Continued)
TABLE 1 | Continued
miRNA Fold change P-value
mmu-miR-7a −8.35 0.00062
mmu-miR-9 −3.88 0.01623
mmu-miR-92a −4.34 0.01318
mmu-miR-93 −6.98 0.01638
mmu-miR-99b −3.56 0.02227
FIGURE 1 | Validation of selected miRNAs array data by Real-time
PCR. Graphs indicate relative expression of (A) mir-133a (B) mir-133b (C)
mir-9 (D) mir-29 (E) mir-330 (F) mir-1. White bar refers to wild type (Wt) and
black bar to MLC/SOD1G93A (Tg). Values are expressed as mean ± SEM.
*p < 0.05 (n = 10 for each group).
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TABLE 2 | List of significantly up-regulated genes in MLC/SOD1G93A
spinal cord.
Gene
symbol
Gene name Fold change P-value
Arhgap19 Rho GTPase activating protein 19 +2.14 0.018071
Arl4d ADP-ribosylation factor-like 4D +1.51 0.026430
Art3 ADP-ribosyltransferase 3 +1.63 0.003088
Ccdc37 Coiled-coil domain containing 37 +1.67 0.013866
Chrdl1 Chordin-like 1 +1.96 0.010071
Cldn19 Claudin 19 +1.74 0.014558
Ddn Dendrin +1.51 0.022150
Dhh Desert hedgehog +1.86 0.021201
Drp2 Dystrophin related protein 2 +1.79 0.012309
Egr2 Early growth response 2 +1.70 0.022549
Gas2l3 Growth arrest-specific 2 like 3 +2.05 0.030748
Gimap1 GTPase, IMAP family member 1 +1.59 0.047143
Gldn Gliomedin +1.77 0.010186
Gulp1 GULP, engulfment adaptor +1.63 0.006082
Hif3a Hypoxia inducible factor 3, alpha
subunit
+1.57 0.014288
Hist2h2ab Histone cluster 2, H2ab +1.56 0.002544
Hoxc13 Homeobox C13 +1.60 0.045743
Hoxd10 Homeobox D10 +2.13 0.043521
Il16 Interleukin 16 +1.64 0.011144
Inmt Indolethylamine
N-methyltransferase
+1.91 0.016648
Krtap4-2 Keratin associated protein 4-2 +1.54 0.005207
Matn2 Matrilin 2 +1.74 0.006453
Mertk c-mer proto-oncogene tyrosine
kinase
+1.80 0.003151
Mme Membrane metallo
endopeptidase
+1.58 0.018812
Mpz Myelin protein zero +1.64 0.049548
Nr4a2 Nuclear receptor subfamily 4,
group A, member 2
+1.52 0.013349
Ogn Osteoglycin +2.02 0.041760
Olfr102,
Olfr100
Olfactory receptor 102,100 +2.07 0.001166
Olfr128 Olfactory receptor 128 +1.78 0.025072
Olfr1283 Olfactory receptor 1283 +1.52 0.030795
Plekha4 Pleckstrin homology domain
containing, family A
+2.01 0.020446
Pmp22 Peripheral myelin protein 22 +1.57 0.022466
Prrg4 Proline rich Gla
(G-carboxyglutamic acid) 4
+1.66 0.000427
Prx Periaxin +1.98 0.019790
Rabggtb, RAB geranylgeranyl transferase, b
subunit
+1.77 0.041637
Rdh13 Retinol dehydrogenase 13
(all-trans and 9-cis)
+2.30 0.034523
Rhox2h Reproductive homeobox 2H +1.72 0.044442
Rpl31-ps4 Ribosomal protein L31,
pseudogene 4
+1.61 0.004327
Sbp Spermine binding protein +1.60 0.000512
(Continued)
TABLE 2 | Continued
Gene
symbol
Gene name Fold change P-value
Sbspon somatomedin B and
thrombospondin
+1.66 0.009017
Slc36a2 Solute carrier family 36, member 2 +2.24 0.004210
Smco3 Single-pass memb. protein
coiled-coil domains 3
+1.52 0.004448
Smtn Smoothelin +1.55 0.028145
Snhg3 Small nucleolar RNA host gene 3 +2.65 0.016377
Snora17 Small nucleolar RNA, H/ACA box
17,
+2.74 0.027109
Snora73b, Small nucleolar RNA, H/ACA box
73b,
+2.23 0.025905
Sostdc1 Sclerostin domain containing 1 +1.68 0.007660
Tdpoz1 TD and POZ domain containing 1 +1.68 0.010976
Tgfbi Transforming growth factor, beta
induced
+1.83 0.027616
Th Tyrosine hydroxylase +1.72 0.025458
Vmn1r181 Vomeronasal 1 receptor 181 +1.51 0.042949
Xlr4b X-linked lymphocyte-regulated 4B +1.88 0.005473
Zbtb16 Zinc finger and BTB domain
containing 16
+1.53 0.018846
Zfp37 Zinc finger protein 37 +1.54 0.000034
the ventral root of the lumbar spinal cord of transgenic
mice.
Functional Annotation of the Identified
Genes
Functional annotation of differentially expressed genes was
performed using the DAVID functional annotation tool, an
integrated biological knowledge base and analytic tools aimed
at systematically extracting biological meaning from large gene
and protein lists (Huang da et al., 2009). Similar annotation
contents were clustered into annotation group with biological
meanings. The annotation results revealed that 2.6% of the gene
list examined was consistent with OMIM disease categories,
in particular 5 of 17 genes extracted were related to Charcot-
Marie-Tooth disease. On the other hand, the gene ontology
analysis revealed that 39.3% of all gene list are significantly
involved in biological processes category, 36.7% are part of
cell components, and 39.8% are associated with molecular
function categories. The nine interesting genes mentioned above
were spread out in all the categories examined. The functional
annotation clustering was done using the default parameters,
Mus musculus as background and classification stringency was
set as medium. Table 4 shows that the significantly modulated
genes were involved in 5 functional clusters containing functional
annotation for extracellular region, neuron development and
differentiation, axonogenesis, and neurological system process.
A further functional analysis was performed using STRING, a
web base tool to explore potential protein-protein interaction,
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TABLE 3 | List of significantly down-regulated genes in MLC/SOD1G93A
spinal cord.
Gene symbol Gene name Fold
change
P-value
Akr1c20 Aldo-keto reductase family 1,
member C
−1.64 0.031454
Aplnr Apelin receptor −1.78 0.020211
C3,
LOC100048759
Complement component 3,
complement C3-like
−1.60 0.044240
Cyp2j12 Cytochrome P450, family 2,
subfamily j, polypeptide 12
−1.58 0.018190
Enpp6 Ectonucleotide
pyrophosphatase/
phosphodiesterase 6
−1.58 0.015427
Frmpd4 FERM and PDZ domain
containing 4
−1.66 0.010645
Gbp4 Guanylate binding protein 4 −1.65 0.027557
Gm14257 Predicted gene 14257 −1.54 0.032704
Gm15246,
BC022960
Predicted gene 15246, cDNA
sequence BC022960
−1.84 0.029954
Gm3088 Predicted gene 3088 −1.61 0.048993
Klk6 Kallikrein related-peptidase 6 −1.70 0.005161
mt-Tt Mitochondrially encoded tRNA
threonine
−1.52 0.036295
Nkx2-9 NK2 transcription factor related,
locus 9 (Drosophila)
−1.51 0.007001
Olfr611 Olfactory receptor 611 −4.75 0.000275
Olfr727 Olfactory receptor 727 −1.51 0.043050
Opalin Oligodendrocytic myelin
paranodal and inner loop prot.
−1.75 0.000707
Pi15 Peptidase inhibitor 15 −1.52 0.020502
Prok2 Prokineticin 2 −1.54 0.040329
Prps2 Phosphoribosyl pyrophosphate
synthetase 2
−1.60 0.034506
Serpina1c Serine peptidase inhibitor, clade
A, member 1C
−1.66 0.024381
Vmn1r37 Vomeronasal 1 receptor 37 −1.62 0.023405
Vmn2r71 Vomeronasal 2, receptor 71 −1.70 0.033296
Vnn1 Vanin 1 −1.65 0.010154
confirming the interactions among Pmp22, Mpz, Prx, and Egr2
proteins (Figure 4).
Correlation of Expression Profile between
miRNAs and mRNA
miRNAs are key regulators of all important biological processes
and the level at which they act on coding mRNA (transcriptional,
translational, etc.) is still debated; however gene repression
by microRNAs at the level of mRNA translation is the
most frequently reported mechanism (Morozova et al., 2012).
Therefore, we further performed a systematic analysis on
the interaction between significantly modulated miRNAs and
mRNAs considering only miRNAs present in our list with
an inverse mRNAs expression correlation. The analysis was
performed using MiRwalk tool a comprehensive database that
provides information on miRNA produced by 8 established
FIGURE 2 | Validation of selected mRNAs by Real-time PCR. Graphs (A)
Pmp 22 (B) Prx (C) Mpz (D) Opalin (E) Egr2. White bar refers to wild type (Wt)
and black bar to MLC/SOD1G93A (Tg). Values are expressed as mean ± SEM.
*p < 0.05 compared to Wt (n = 4 for each group).
miRNA prediction programs on 3′ UTRs of all known genes of
mouse such as RNA22, miRanda, miRDB, TargetScan. Secondly,
we ordered mRNAs on the basis of the number of putative
targeting miRNAs and we observed that 36 genes were targeted
from at least 1 to maximum 30 significantly modulated miRNAs;
conversely 54 listed miRNAs targeted at least one to maximum
of 11 significantly modulated genes; interestingly the most
intriguing cross interaction involved genes and miRNAs of the
myelination process (Table 5).
This finding clearly suggests that muscle specific
overexpression of the SOD1mutant gene induces themodulation
of miRNAs and putative targeted-mRNAs involved in the
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FIGURE 3 | Validation of selected factors by western blot analysis.
Graphs and representative western blot for (A) Pmp 22 and (B) Mpz. White
bar refers to wild type (Wt) and black bar to MLC/SOD1G93A (Tg). Values are
expressed as mean ± SEM. *p < 0.05; **p < 0.005 compared to Wt (n = 5 for
each group).
myelination process in the spinal cord of MLC/SOD1G93A
transgenic mice.
Mapping miRNAs to Signaling Pathways
DIANA-mirPath is a web-based computational tool to identify
KEGG signaling pathways regulated by miRNAs (see Materials
andMethods section). The software compares each set of miRNA
targets with all-known KEGG pathway and interestingly we
observed high significance for axon guidance, glutamatergic
synapse, and amyotrophic lateral sclerosis (ALS), meaning that
these pathways are likely to be controlled by the altered miRNAs
(Table 6).
Muscle Specific Expression of SOD1
Mutant Gene Induces Hypomyelination in
the Mice Sciatic Nerve
Different reports indicate that ALS might be associated with
motor nerve fiber (Echaniz-Laguna et al., 2006; Rajabally and
Jacob, 2008; Ahdab et al., 2013). Previously, we demonstrated
that the peripheral nerve was severely compromised in
the global SOD1G93A mutant mice, which displayed loss
of Schmidt-Lantermann incisures, a disproportionately thick
myelin sheath, abundant double onion bulb structures, and
increased demyelinated axons (Dobrowolny et al., 2008a). To
assess whether muscle specific expression of SOD1 mutant gene
induces a peripheral alteration of axon myelination we calculated
the ratio of axon diameter to total fiber diameter (g-ratio)
(Michailov et al., 2004). The Figure 5A shows the cross-sections
of wild type and MLC/SOD1G93A sciatic nerves stained with
toluidine blue. The histological analysis of the peripheral nerve
of the MLC/SOD1G93A displayed the presence of double onion
bulb structures. Moreover, the g-ratio in the transgenic sciatic
TABLE 4 | Functional annotation clustering of up-regulated mRNAs.
Annotation cluster 1 Enrichment score: 1.85
Category Count P-value
GOTERM_CC_FAT extracellular region 15 2.7E-3
GOTERM_CC_FAT extracellular region part 8 2.4E-2
GOTERM_CC_FAT extracellular space 6 4.2E-2
Annotation cluster 3 Enrichment score: 0.95
GOTERM_BP_FAT neuron development 5 1.4E-2
GOTERM_MF_FAT transcription factor activity 7 3.8E-2
GOTERM_BP_FAT neuron differentiation 5 4.0E-2
Annotation cluster 4 Enrichment score: 0.87
GOTERM_CC_FAT extracellular region part 8 2.4E-2
Annotation cluster 5 Enrichment score: 0.8
GOTERM_BP_FAT locomotory behavior 5 7.3E-3
GOTERM_BP_FAT behavior 6 9.6E-3
GOTERM_BP_FAT pattern specification process 5 1.3E-2
GOTERM_BP_FAT neuron development 5 1.4E-2
GOTERM_BP_FAT response to endogenous stimulus 4 2.2E-2
GOTERM_BP_FAT regionalization 4 3.2E-2
GOTERM_MF_FAT transcription factor activity 7 3.8E-2
GOTERM_BP_FAT neuron differentiation 5 4.0E-2
Annotation cluster 7 Enrichment score: 0.53
GOTERM_BP_FAT neurological system process 11 3.9E-2
Annotation cluster means a group of terms having similar biological functions. Enrichment
score is the rank of the annotation cluster biological significance. Count column refers to
number of genes involved in the same category.
nerves was significantly increased (Figure 5B) independently of
the axonal diameter (Figure 5C), indicating that muscle specific
expression of SOD1mutant gene induces hypomyelination in the
sciatic nerve of transgenic mice.
DISCUSSION
The functional interplay between muscle and nerve is crucial
for the survival and function of both tissues throughout life and
ALS represents one of the best examples of impaired interplay
between the two tissues (Musarò, 2013). Although, there have
been significant advances in our understanding of the biology
of ALS, no consensus has emerged as to which cells, tissues and
pathways are directly affected by mutant SOD1. Motor neurons
degeneration and muscle atrophy are the major pathological
processes associated with ALS consistent with the role of nerve
activity in muscle homeostasis and remodeling (Munson et al.,
1997; Pette, 2001; Schiaffino et al., 2007). However, other cells
may be involved in the pathogenesis of ALS and alteration
in skeletal muscle homeostasis might represent one of the
critical mediators of motor neuron degeneration. This hypothesis
has been recently investigated by different groups, and we
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FIGURE 4 | STRING analysis of pathway enrichment and interaction in the altered mRNAs of the MLC/SOD1G93A transgenic mice. Protein products of
five modulated mRNAs (Drp2, Prx, Egr2, Mpz, and Pmp22) were involved in eight interactions.
recently demonstrated that muscle selective expression of SOD1
mutation causes pathological alterations in skeletal muscle and
induces pre-symptomatic sign of ALS at the level of spinal cord
(Dobrowolny et al., 2008b).
In the present study, we extended our previous work and
analyzed whether muscle-specific expression of SOD1G93A is
able to affect the expression of non-coding RNA and mRNA in
the spinal cord of MLC/SOD1G93A transgenic mice, compared
with wild type littermates. Our findings are in agreement with
previous studies showing that skeletal muscle is also a source
of signals that influence neuron survival, axonal growth and
maintenance of synaptic connections (Funakoshi et al., 1995;
Dobrowolny et al., 2005). In the absence of trophic support,
muscle can have a negative impact on the nervous system,
and therefore, can contribute to the alteration in the functional
connection between muscle and nerve.
The major findings of our study indicate that muscle-specific
expression of SOD1G93A can modulate relevant molecules of
the genetic and epigenetic circuitry of the myelin homeostasis
in the spinal cord of transgenic mice. In particular, we found
down regulation of mir-1, mir-330, mir-29, mir-133, and mir-9
family members, whose dysregulation can have profound effects
on neuronal physiology and pathology, including Huntington,
Alzheimer, and Parkinson diseases (Saito and Saito, 2012).
Although, it is known that deregulation of specific miRNA-
dependent regulatory circuitries correlates with the initiation
and progression of several neurological disorders, the underlying
mechanisms of these phenomena are still not fully understood.
Here we revealed the alteration of specific microRNAs and
potential mRNA targets, which might be part of the short
circuit that disrupts the communication between skeletal muscle
and nerve and that might be part of the so called dying back
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TABLE 5 | List of selected genes and corresponding regulated miRNAs.
Gene miRNA miRNA Gene
Egr2 mmu-miR-93 mmu-miR-1 Cldn19
mmu-miR-17 DrP2
mmu-miR-20b Mpz
Mpz mmu-miR-1 Nr4a2
mmu-miR-129-3p Ogn
mmu-miR-133a Prx
mmu-miR-133b Drp2
mmu-miR-192 mmu-miR-9 Dhh
mmu-miR-30a Mme
mmu-miR-30e Pmp22
mmu-miR-329 Prx
mmu-miR-491 Rdh13
Pmp22 mmu-miR-26b Tgfbi
mmu-miR-29a mmu-miR-15 Cldn19
mmu-miR-29b Gldn
mmu-miR-29c Prx
mmu-miR-330 Rdh13
mmu-miR-340-3p
mmu-miR-501-3p mmu-miR-29 Drp2
mmu-miR-544 Gldn
mmu-miR-9 Pmp22
Prx mmu-miR-1 mmu-miR-133 a–b Cldn19
mmu-miR-106a Mpz
mmu-miR-10a Rdh13
mmu-miR-10b
mmu-miR-128
mmu-miR-129-3p
mmu-miR-15a
mmu-miR-15b
mmu-miR-17
mmu-miR-188-5p
mmu-miR-206
mmu-miR-20b
mmu-miR-328
mmu-miR-330
mmu-miR-491
mmu-miR-497
mmu-miR-7a
mmu-miR-9
mmu-miR-93
Schematic representation of the inversely correlated miRNAs and predicted targets based
on Mirwalk analysis.
phenomenon (Dadon-Nachum et al., 2011). In particular, among
transcripts that are potential targets of the altered miRNAs, we
revealed the presence of relevant markers of myelin homeostasis
that are modulated by muscle restricted expression of SOD1
mutation inducing hypomyelination of the peripheral nerve.
The up-regulation of Pmp22 and Mpz proteins in the spinal
cord of MLC/SOD1G93A paralleled that of mRNA expression
and supports the evidence that these factors are molecular
targets of microRNAs, such as miR-1, miR-9, miR-133, and
miR-330, that resulted differently modulated in the spinal cord
of MLC/SOD1G93A mice compared to wild type littermates.
TABLE 6 | Signaling pathways predicted to be regulated by miRNAs.
KEGG Pathway P-value Number of miRNA
PI3K-Akt signaling pathway 5.368871e-57 48
MAPK signaling pathway 2.427724e-54 46
Focal adhesion 9.558692e-36 44
Wnt signaling pathway 1.247526e-33 42
Axon guidance 3.168282e-33 42
Ubiquitin mediated proteolysis 3.031889e-27 37
Neurotrophin signaling pathway 3.031889e-27 42
Insulin signaling pathway 1.208302e-26 45
ErbB signaling pathway, 6.307645e-22 46
Transcriptional misregulation in cancer 9.134568e-22 45
Protein processing in endoplasmic reticulum 1.448874e-21 40
TGF-beta signaling pathway 4.891741e-21 36
HIF-1 signaling pathway 2.055494e-20 43
Adherens junction 4.208319e-16 36
Jak-STAT signaling pathway 2.747301e-15 39
mTOR signaling pathway 1.21693e-14 38
VEGF signaling pathway 1.531543e-13 38
Glutamatergic synapse 1.114872e-10 38
Amyotrophic lateral sclerosis (ALS) 7.053373e-10 34
Notch signaling pathway 9.441105e-09 29
Toll-like receptor signaling pathway 3.1133e-08 35
Circadian rhythm 8.717738e-08 32
Dorso-ventral axis formation 3.707892e-06 28
Adipocytokine signaling pathway 8.449379e-06 33
Dopaminergic synapse 1.421481e-05 38
Dilated cardiomyopathy 6.37123e-05 35
Cholinergic synapse 0.0001426234 36
Protein digestion and absorption 0.0004322993 35
mRNA surveillance pathway 0.0005316409 36
Cytokine-cytokine receptor interaction 0.00200525 43
Calcium signaling pathway 0.03407104 42
D-Glutamine and D-glutamate metabolism 0.03934887 5
Carbohydrate digestion and absorption 0.0460262 20
It has been demonstrated that Myelin protein zero is up-
regulated in oligodendroglia following axonal injury (da Silva
et al., 2015) and Periaxin is expressed by myelinating Schwann
cells in association with the dystroglycan complex through
Drp2 (Sherman et al., 2012). Moreover, Pmp22 exhibits a dose
dependent function as both overexpression and deletion result
in hereditary neuropathy (Han et al., 2013). Dhh is essential for
the structural and functional integrity of the peripheral nerve
(Sharghi-Namini et al., 2006) and Osteglycine, Claudin -19 and
Smoothelin together with Pmp22 and Prx are associated with
reduced myelination of the spinal cord in the hypogravity motor
syndrome (Chelyshev et al., 2014). Moreover, mutations in Mpz,
Pmp22, Egr2, and Prx are associated with Charcot–Marie–Tooth
neuropathy in which the over expression of these genes leads to
defective myelination processes.
Recently, some specific miRNAs, such as miR-9, miR-23,
and miR-29a, were found to participate in the regulation of
oligodendrocyte differentiation and myelin maintenance, as well
as in the pathogenesis of demyelination-related diseases. These
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FIGURE 5 | Hypomyelination in the sciatic nerve of MLC/SOD1G93A
mice. (A) Photographs showing the mouse sciatic nerve strained with
toluidine blue. White arrowhead indicates onion bulb structure (40X
magnification) Scale bar = 20µm. (B) The average g-ratios. (C) The average
g-ratio for each axonal diameter (1–3, 3–5, 5–7, >7µm). Values are expressed
as mean ± SEM fibers. *p < 0.05; ****p < 0.0001 compared to wild type (Wt).
miRNAs control their target mRNAs and are involved in the
pathogenesis of demyelination-related diseases (Lau et al., 2008;
Verrier et al., 2009; Li and Yao, 2012).
Regarding the mRNA-miRNA interplay, most of the putative
interactions proposed here have not been previously described
and deserve further investigation. Interestingly, the functional
interaction of miR-9 with Peripheral myelin protein 22 (Pmp22)
mRNA has been already demonstrated (Lau et al., 2008). In
particular, miR-9 is down-regulated during oligodendrocyte
differentiation and its expression level inversely correlates with
the expression of its targets Pmp22. Moreover, it has been
described that the inhibition of endogenous miR-29 overrides the
miRNA-mediated repression of Pmp22 cultured Schwann cells
during both development and post-crush injury (Verrier et al.,
2009). Therefore, these data suggest that myelin gene expression
is regulated by miRNAs.
Here we observed that the muscle specific expression of
the SOD1 mutant gene induces the deregulation of both mir-9
and 29 together with myelin alteration in the sciatic nerve.
These data have been validated by histological analysis of the
sciatic nerve that shows a reduction in the myelin sheath in
the MLC/SOD1G93A mice model. In this regard it is interesting
to note that the classical oligodendrocyte markers were down-
regulated (considering a fold change < 1.5 olig2 FC = −1.3
p = 0.02; Nkx2-2 FC = −1.36; p = 0.008; Mag FC = −1.39,
p = 0.01). Therefore the reduction in oligodendrogenesis could
be correlated with the hypomyelination in the MLC/SOD1G93A
mouse model.
In the spinal cord of SOD1G93A transgenic mice that
ubiquitously express the mutant SOD1 gene, the miRNA-9
expression is up-regulated (Zhou et al., 2013). In this model there
is extensive degeneration of gray matter oligodendrocytes in the
spinal cord prior to disease onset; actually new oligodendrocytes
were formed but they failed to mature, resulting in progressive
demyelination (Kang et al., 2013). The difference in the
expression levels of miRNA-9 between the global SOD1G93A
and MLC/SOD1G93A mice is likely due to SOD1G93A gene
ubiquitously expressed in all tissues, including muscle, motor
neurons and glia. This might generate a synergistic toxic effect,
leading to a more severe phenotype.
Although, most of the miRNA and mRNA inverted
correlations proposed here have not been yet validated, the
elevated number of potential interactions strongly points toward
a role of skeletal muscle in myelin homeostasis. Nevertheless,
although these results point toward some mechanisms of action
of muscle specific expression of SOD1G93A at the level of spinal
cord, the elevated number of potential targets of the analyzed
miRNAs make these mechanisms only mere suggestions.
Additional studies will define which cell types, at the levels of
spinal cord of MLC/SOD1G93A mice, specifically exhibit changes
in microRNAs and mRNAs.
Overall our study provides additional insights into the
effects of muscle selective expression of SOD1G93A on nerve
homeostasis and reveals the potential miRNA and mRNA
signature associated with the dying back phenomenon.
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